The global medical polyoxymethylene market size is expected to reach USD 2.5 billion by 2033, growing at a CAGR of 8.7% from 2026 to 2033, according to a new study by Grand View Research, Inc. The market is predicted to grow significantly in the coming years as demand for medical devices and equipment rises. Polyoxymethylene is a material that is extensively used in the manufacture of several medical devices such as catheters, surgical instruments, implants, and drug delivery systems.
The growing elderly population and the rise in chronic diseases are also driving market expansion, and increasing demand for medical devices and equipment. Furthermore, rising awareness of the benefits of employing POM in medicinal applications, as well as technological advancements, are propelling the market forward.
Several drug delivery device manufacturers are focusing on creating complex products by utilizing high-performance materials with improved physical and mechanical properties, along with advanced functionality and improved aesthetics, which could align with the cost-effectiveness and goal of meeting complexity. Thus, manufacturers are developing the usage of polyoxymethylene (POM) in medication delivery systems to meet the increasing demand.
The expansion of the medical sector in developing nations such as China, South Korea, and India provides lucrative potential for the growth of the Asia Pacific medical polyoxymethylene market. Due to their well-established healthcare infrastructure and rising acceptance of new medical technologies, North America and Europe are also projected to witness significant development. Another element boosting the industry in the region is the easy accessibility and availability of raw materials, combined with cost-effective labor and low production costs.
Request a free sample copy or view report summary: Medical Polyoxymethylene Market Report
The copolymer segment dominated the market with 63.4% share of the global revenue in 2025. Copolymer POM offers improved dimensional stability and a reduced prospect of formaldehyde emissions when exposed to heat or moisture, making it the favored option for applications that demand long-lasting reliability and adherence to strict biocompatibility criteria.
Insulin pen dominated the market with 34.7% share of the global revenue in 2025. The growth is fueled by the growing incidence of diabetes and the heightened use of reusable and smart insulin pens, which necessitate components that are precise, chemically resistant, and durable, characteristics that POM readily offers.
Asia Pacific medical polyoxymethylene market dominated and accounted for 45.7% share of the global revenue in 2025.
Grand View Research has segmented the global medical polyoxymethylene market on the basis of type, application, and region:
Medical Polyoxymethylene Type Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
Homopolymer POM
Copolymer POM
Medical Polyoxymethylene Application Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
Dialysis Machine
Handles for Surgical Instruments
Inhalers
Insulin Pen
Medical Trays
Pharmaceutical Closures
Other Applications
Medical Polyoxymethylene Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Norway
Denmark
Asia Pacific
China
India
Japan
South Korea
Australia
Malaysia
Singapore
Thailand
Vietnam
Central & South America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
UAE
South Africa
List of Key Players of Medical Polyoxymethylene Market
Kolon ENP
BASF SE
Celanese Corporation
Polyplastics Co., Ltd.
ASAHI KASEI CORPORATION
SABIC
Delrin USA, LLC
Ensinger
GLOBAL POLYACETAL CO., LTD.
"The quality of research they have done for us has been excellent..."